Shareholder alert: levi & korsinsky, llp reminds shareholders of revance therapeutics, inc. a class action lawsuit and a lead plaintiff deadline of february 8, 2022 - rvnc

New york, jan. 20, 2022 /prnewswire/ -- the following statement is being issued by levi & korsinsky, llp: to: all persons or entities who purchased or otherwise acquired securities of revance therapeutics, inc. ("revance" or the "company") (nasdaq: rvnc)  between november 25, 2019 and october 11, 2021 .  you are hereby notified  that a securities class action lawsuit has been commenced in the united states district court for the northern district of california.
RVNC Ratings Summary
RVNC Quant Ranking